Anti-Platelet Drugs

Definition of Anti-Platelet Drugs

• Anti-Platelet Drugs agents inhibit platelet aggregation and activation, thereby preventing thrombus formation.

Classes of Anti-Platelet Agents

1. Aspirin (Acetylsalicylic Acid):

   • Mechanism: Irreversibly inhibits cyclooxygenase-1 (COX-1), reducing thromboxane A2 synthesis, which decreases platelet aggregation.
   • Use: Prevention of AMI, stroke, and in peripheral arterial disease.
   • Side Effects: Gastrointestinal ulcers, bleeding, Reye’s syndrome in children.

2. P2Y12 Inhibitors (e.g., Clopidogrel, Prasugrel, Ticagrelor):

   • Mechanism: Block the ADP receptor on platelets, inhibiting platelet activation and aggregation.
   • Use: Acute coronary syndrome, post-percutaneous coronary intervention (PCI), stroke prevention.
   • Side Effects: Bleeding, thrombotic thrombocytopenic purpura (rare with some agents).

3. Glycoprotein IIb/IIIa Inhibitors (e.g., Abciximab, Eptifibatide, Tirofiban):

   • Mechanism: Block the final common pathway for platelet aggregation by inhibiting glycoprotein IIb/IIIa receptors.
   • Use: During PCI, acute coronary syndromes.
   • Side Effects: Bleeding, thrombocytopenia.

4. Phosphodiesterase Inhibitors (e.g., Dipyridamole):

   • Mechanism: Increase cyclic AMP levels in platelets, inhibiting aggregation.
   • Use: Often combined with aspirin for stroke prevention.
   • Side Effects: Headache, dizziness, gastrointestinal upset.

5. Thienopyridines (e.g., Ticlopidine):

   • Mechanism: Similar to clopidogrel; inhibit ADP-mediated platelet activation.
   • Use: Similar to other P2Y12 inhibitors.
   • Side Effects: Neutropenia, thrombotic thrombocytopenic purpura.

Clinical Indications:

• Primary and Secondary Prevention of Atherosclerotic Events: Including AMI, stroke, and peripheral arterial disease.
• Acute Coronary Syndromes (ACS): Used in combination with other therapies during and after interventions like PCI.
• Atrial Fibrillation: As an alternative to anticoagulation in certain cases.

Clinical Considerations:

• Combination Therapy: Often used alongside anticoagulants (e.g., dual antiplatelet therapy with aspirin and clopidogrel).
• Bleeding Risk: Increased risk of gastrointestinal bleeding, intracranial hemorrhage.
• Resistance and Non-responsiveness: Some patients exhibit resistance to aspirin or clopidogrel, necessitating alternative therapies.
• Side Effects: Gastrointestinal irritation (aspirin), bleeding complications, thrombocytopenia (GP IIb/IIIa inhibitors).

Thank you for reading from Firsthope's notes, don't forget to check YouTube videos!